Banner - Collaborative Care Symposium

News
Media
Conferences
Events
Publications
CME
Partners
Subscribe
Resources

Branded vs generics: You make the call in dry eye

Generic vs. Branded Ophthalmic Medications

EP. 1: Generic vs. Branded Ophthalmic Medications

July 1st 2020

Cost and Substitution Issues

EP. 2: Cost and Substitution Issues

July 1st 2020

Patient Counseling on Generic vs. Branded

EP. 3: Patient Counseling on Generic vs. Branded

July 1st 2020

Dry Eye Disease Epidemiology

EP. 4: Dry Eye Disease Epidemiology

July 1st 2020

Impact of Dry Eye on Surgical Outcome; Patient Screening

EP. 5: Impact of Dry Eye on Surgical Outcome; Patient Screening

July 1st 2020

Glaucoma Medications and Dry Eye Disease

EP. 6: Glaucoma Medications and Dry Eye Disease

July 1st 2020

Initiating Anti-Inflammatory/Immunomodulatory Therapy

EP. 7: Initiating Anti-Inflammatory/Immunomodulatory Therapy

July 1st 2020

Cyclosporine Formulation Challenges

EP. 8: Cyclosporine Formulation Challenges

July 1st 2020

Lifitegrast Experience and Patient Counseling

EP. 9: Lifitegrast Experience and Patient Counseling

July 1st 2020

Role of the Technician

EP. 10: Role of the Technician

July 1st 2020

The Technician’s Role

EP. 11: The Technician’s Role

July 1st 2020

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Metformin use associated with reduced incidence of intermediate AMD

MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio

Last year in glaucoma at EnVision Summit 2025

Looking back at the 2025 EnVision Summit

Sandoz Canada launches aflibercept biosimilar, Enzeevum